MAIO MICHELE

Contacts

Curriculum Vitae

Teaching activities

Completion accademic year: 2025/2026

Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025
Course year: 6 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021
Course year: 6 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021

Completion accademic year: 2024/2025

Course year: 6 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020
Course year: 6 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020

Completion accademic year: 2023/2024

Research

Ultime pubblicazioni:

  • Di Giacomo, A.M., Subudhi, S., Vos, W., Andreatta, M., Carmona, S., Mctavish, W., et al. (2025). Perspectives on the role of “-Omics” in predicting response to immunotherapy. EUROPEAN JOURNAL OF CANCER, 220 [10.1016/j.ejca.2025.115393]. - view more
  • Di Giacomo, A.M., Bartalini, S., D'Alonzo, V., Cerase, A., Cutarella, S., Rossi, G., et al. (2025). Neurological adverse events of ICI therapy: A ten-year comprehensive management from a multidisciplinary team. EUROPEAN JOURNAL OF CANCER, 228 [10.1016/j.ejca.2025.115707]. - view more
  • Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03310-0]. - view more
  • Solmonese, L., Lofiego, M.F., Fazio, C., Marzani, F., Piazzini, F., Bello, E., et al. (2025). The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. ONCOTARGETS AND THERAPY, 18, 995-1012 [10.2147/OTT.S527785]. - view more
  • Anichini, A., Caruso, F.P., Lagano, V., Noviello, T.M.R., Tufano, R., Nicolini, G., et al. (2025). Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03474-9]. - view more